Javascript must be enabled to continue!
Enhancing Sumoylation Site Prediction: A Deep Neural Network with Discriminative Features
View through CrossRef
Sumoylation is a post-translation modification (PTM) mechanism that involves many critical biological processes, such as gene expression, localizing and stabilizing proteins, and replicating the genome. Moreover, sumoylation sites are associated with different diseases, including Parkinson’s and Alzheimer’s. Due to its vital role in the biological process, identifying sumoylation sites in proteins is significant for monitoring protein functions and discovering multiple diseases. Therefore, in the literature, several computational models utilizing conventional ML methods have been introduced to classify sumoylation sites. However, these models cannot accurately classify the sumoylation sites due to intrinsic limitations associated with the conventional learning methods. This paper proposes a robust computational model (called Deep-Sumo) for predicting sumoylation sites based on a deep-learning algorithm with efficient feature representation methods. The proposed model employs a half-sphere exposure method to represent protein sequences in a feature vector. Principal Component Analysis is applied to extract discriminative features by eliminating noisy and redundant features. The discriminant features are given to a multilayer Deep Neural Network (DNN) model to predict sumoylation sites accurately. The performance of the proposed model is extensively evaluated using a 10-fold cross-validation test by considering various statistical-based performance measurement metrics. Initially, the proposed DNN is compared with the traditional learning algorithm, and subsequently, the performance of the Deep-Sumo is compared with the existing models. The validation results show that the proposed model reports an average accuracy of 96.47%, with improvement compared with the existing models. It is anticipated that the proposed model can be used as an effective tool for drug discovery and the diagnosis of multiple diseases.
Title: Enhancing Sumoylation Site Prediction: A Deep Neural Network with Discriminative Features
Description:
Sumoylation is a post-translation modification (PTM) mechanism that involves many critical biological processes, such as gene expression, localizing and stabilizing proteins, and replicating the genome.
Moreover, sumoylation sites are associated with different diseases, including Parkinson’s and Alzheimer’s.
Due to its vital role in the biological process, identifying sumoylation sites in proteins is significant for monitoring protein functions and discovering multiple diseases.
Therefore, in the literature, several computational models utilizing conventional ML methods have been introduced to classify sumoylation sites.
However, these models cannot accurately classify the sumoylation sites due to intrinsic limitations associated with the conventional learning methods.
This paper proposes a robust computational model (called Deep-Sumo) for predicting sumoylation sites based on a deep-learning algorithm with efficient feature representation methods.
The proposed model employs a half-sphere exposure method to represent protein sequences in a feature vector.
Principal Component Analysis is applied to extract discriminative features by eliminating noisy and redundant features.
The discriminant features are given to a multilayer Deep Neural Network (DNN) model to predict sumoylation sites accurately.
The performance of the proposed model is extensively evaluated using a 10-fold cross-validation test by considering various statistical-based performance measurement metrics.
Initially, the proposed DNN is compared with the traditional learning algorithm, and subsequently, the performance of the Deep-Sumo is compared with the existing models.
The validation results show that the proposed model reports an average accuracy of 96.
47%, with improvement compared with the existing models.
It is anticipated that the proposed model can be used as an effective tool for drug discovery and the diagnosis of multiple diseases.
Related Results
TRIM28 Facilitates Chronic Myeloid Leukemia Progression By Enhancing Sumoylation and Stability of BCR-ABL
TRIM28 Facilitates Chronic Myeloid Leukemia Progression By Enhancing Sumoylation and Stability of BCR-ABL
Chronic myeloid leukemia (CML) is a hematopoietic malignancy caused by the BCR-ABL fusion gene. Although tyrosine kinase inhibitors (TKIs) targeting the oncoprotein BCR-ABL have dr...
Regulation of Enhancers by SUMOylation Through TFAP2C Binding and Recruitment of HDAC Complex to the Chromatin
Regulation of Enhancers by SUMOylation Through TFAP2C Binding and Recruitment of HDAC Complex to the Chromatin
Abstract
Enhancers are fundamental to gene regulation. Post-translational modifications by the small ubiquitin-like modifiers (SUMO) modify chromatin regulation enzymes, in...
SUMOylation Regulates Transcription by the Progesterone Receptor A Isoform in a Target Gene Selective Manner
SUMOylation Regulates Transcription by the Progesterone Receptor A Isoform in a Target Gene Selective Manner
Luminal breast cancers express estrogen (ER) and progesterone (PR) receptors, and respond to endocrine therapies. However, some ER+PR+ tumors display intrinsic or acquired resistan...
Non-SUMOylated alternative spliced isoforms of alpha-synuclein are more aggregation-prone and toxic
Non-SUMOylated alternative spliced isoforms of alpha-synuclein are more aggregation-prone and toxic
Abstract
Background:
To date, four alternative splicing isoforms arising from exon skipping have been identified for α-Synuclein (α-Syn), the main constituent of the abnor...
Aspergillus SUMOylation mutants have normal dynein function but exhibit chromatin bridges
Aspergillus SUMOylation mutants have normal dynein function but exhibit chromatin bridges
Abstract
Functions of protein SUMOylation remain incompletely understood in different cell types. The budding yeast SUMOylation ...
OR11-02 Structural Determinants of Pure Antiestrogenic Activity
OR11-02 Structural Determinants of Pure Antiestrogenic Activity
Abstract
Disclosure: A. Vallet: None. M. Diennet: None. K. Thiombane: None. A. Vivet: None. S. Weber: None. M. El Ezzy: None. F. Shaikh: None. J. Poupart: None. R. M...
SUMOylation in Neural Health and Disease: From Cellular Homeostasis to Neurodegeneration
SUMOylation in Neural Health and Disease: From Cellular Homeostasis to Neurodegeneration
Neurodegenerative diseases (NDDs) represent a growing global health burden, particularly in aging populations. These disorders primarily affect neurons and are characterized by pro...
Fine-tuning of SUMOylation modulates drought tolerance
Fine-tuning of SUMOylation modulates drought tolerance
AbstractSUMOylation is involved in various aspects of plant biology, including drought stress. However, the relationship between SUMOylation and drought stress tolerance is complex...

